可持续鱼油产品的组合疗法:用n-3PUFA和天然成分改善认知功能
Anthony Arsecularatne1,2, Rotina Kapini1,3, Yang Liu1
1NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.
Biomedicines
|June 27, 2024
概括
在临床前研究中,将鱼油 (FO) 与天然产品相结合显示出对认知健康的前景. 然而,临床试验缺乏证据证明这些组合有助于增强认知效益.
科学领域:
- 营养神经科学 营养神经科学
- 食补充剂 食补充剂
- 认知健康 认知健康
背景情况:
- 长链多不和欧米茄-3脂肪酸 (n-3PUFA),特别是鱼油 (FO) 中的多和酸 (DHA) 和乙和酸 (EPA),已被认为是认知增强剂.
- 将FO与天然产品相结合是为了可持续发展和对认知功能的协同效应而探索的.
研究的目的:
- 审查FO (或其成分DHA/EPA) 与天然产品对认知功能保护的联合作用.
- 评估这些组合在认知衰退中的高级影响的证据.
主要方法:
- 对检查FO和天然产品组合的临床前研究和临床试验的审查.
- 对认知功能,神经炎症,氧化应激和神经元生存的影响分析.
主要成果:
- 两项双盲试验显示,使用黄素或维生素E对FO的认知保护没有得到增强.
- 临床前研究表明,在解决认知障碍病理方面,有潜在的益处.
- 目前尚没有关于FO和天然成分组合增强疗效的临床证据.
结论:
- 虽然临床前数据是有希望的,但临床试验尚未支持将FO与天然产品相结合的增强认知益处.
- 需要进一步的研究来协调临床前和临床发现,并验证这些组合对认知衰退的有效性.
更多相关视频
06:00Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development
Published on: March 17, 2023
460
07:05Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
8.9K
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
118
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
118
Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
